Biotechnology & Drugs News


AstraZeneca Prices A Three Tranche Global Bond Offering Totalling $3 Bln

Novartis Announces Positive Results From Phase II ELARA Trial Of Kymriah

Merck Animal Health Completes Acquisition Of Worldwide Rights To VECOXAN From Elanco Animal Health

Sanofi, GSK In Advanced Talks With EU To Supply Up To 300 Mln Doses Of COVID-19 Vaccine

Oxford Biomedica Signs Development, Manufacture & License Agreement With Beam Therapeutics

Roche: European Commission Grants Conditional Marketing Authorisation For Rozlytrek